The present invention relates to compounds of formula (I)
and pharmaceutically acceptable salts and solvates thereof, wherein the substituents are as defined herein, compositions containing such compounds and the uses of such compounds for the treatment of various diseases and conditions such as asthma.
A compound having Formula (I) or Formula (II)
is disclosed as an P2X
7
antagonist, wherein A, B, C, Y, Y, Z, m, v, R
1
, R
2
, R
3
, R
4
, and R
5
, are as defined in the description. Methods and compositions for treating disease or condition modulated by P2X
7
are also disclosed.
A compound having Formula (I) or Formula (II)
is disclosed as an P2X
7
antagonist, wherein A, B, C, Y, Y, Z, m, v, R
1
, R
2
, R
3
, R
4
, and R
5
, are as defined in the description. Methods and compositions for treating disease or condition modulated by P2X
7
are also disclosed.
A compound having Formula (I) or Formula (II)
is disclosed as an P2X
7
antagonist, wherein A, B, C, Y, Y, Z, m, v, R
1
, R
2
, R
3
, R
4
, and R
5
, are as defined in the description. Methods and compositions for treating disease or condition modulated by P2X
7
are also disclosed.
A compound having Formula (I) or Formula (II)
is disclosed as an P2X
7
antagonist, wherein A, B, C, Y, Y, Z, m, v, R
1
, R
2
, R
3
, R
4
, and R
5
, are as defined in the description. Methods and compositions for treating disease or condition modulated by P2X
7
are also disclosed.